Meridian Bioscience's Q2 Revenues Rise 16 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Meridian Bioscience today reported second-quarter revenue growth of 16 percent with double-digit growth for its life science and US diagnostics business.

The Cincinnati-based diagnostics firm reported total revenues of $47.4 million for the three-month period ended March 31, up 16 percent from $41.1 million for the first quarter of 2011. It beat the consensus Wall Street estimate of $44.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.